Chargement en cours...
PUMA mediates the combinational therapy of 5-FU and NVP-BEZ235 in colon cancer
Colon cancer is the third most common cancer in humans which has a high mortality rate, and 5-Fluorouracil (5-FU) is one of the most widely used drugs in colon cancer therapy. However, acquired chemoresistance is becoming the major challenges for patients, and the molecular mechanism underlying the...
Enregistré dans:
| Publié dans: | Oncotarget |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Impact Journals LLC
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4546474/ https://ncbi.nlm.nih.gov/pubmed/25965911 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|